Treatment options to induce remission for paediatric IBD were limited to 5-aminosalicilates, exclusive enteral nutrition (EEN) and corticosteroids until recently, while in adult patients, agents inhibiting tumor necrosis factor alpha (TNF-α) were already established. This evidence concerns the gene TNF and inflammatory bowel disease.